Wall Street Journal: Health Blog

Syndicate content
WSJ's blog on health and the business of health.
Updated: 34 min 7 sec ago

Is Your Spouse Really Your Spouse? A Dependent Audit Wants to Know

Mon, 07/19/2010 - 14:45
With employers searching for ways to control health-care costs, the popularity of dependent audits isn't expected to flag.


Another FDA Advisory Panel Meeting: This Time, It’s Avastin

Mon, 07/19/2010 - 08:19
What will the FDA's oncology-drug panel recommend for Roche's Avastin?


A.M. Vitals: Cigna Eyes Individual Market If Overhaul Makes it Attractive

Mon, 07/19/2010 - 07:43
Also: new temporary insurance pools see abortion coverage restricted; FDA looks at diagnostics.


Why One Stock Research Firm Won’t Cover Obesity Drugs

Fri, 07/16/2010 - 15:42
Is the bar set too high for weight loss drugs?


Health Blog Q&A: $251 Million Medicare Fraud Crackdown

Fri, 07/16/2010 - 14:29
The creator of the Medicare Fraud Strike Force talks with the Health Blog.


Avandia Advice: Talk to Your Doctor. (But What About?)

Fri, 07/16/2010 - 08:52
Whether or not to stay on Avandia will come down to a judgment call.


A.M. Vitals: J&J’s Plan to Fix Plant Includes 300 Layoffs

Fri, 07/16/2010 - 07:28
Also: bad nurses traveling; Boston Scientific's founders sell shares; research on a universal flu vaccine.


Potential XMRV-Chronic Fatigue Syndrome Link Not Easy to Tease Out

Thu, 07/15/2010 - 17:23
Patients aren't going to like this, but it's going to take a while to investigate the potential connection between XMRV and chronic-fatigue syndrome.


FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries

Thu, 07/15/2010 - 16:58
Two other anti-obesity drugs are up for FDA approval.


How Will ‘Meaningful Use’ Factor Into Doctor and Hospital Rankings?

Thu, 07/15/2010 - 15:26
Would you pick a doctor or a hospital if you knew they were more wired?


FDA Panel Math: How Avandia Vote Is Being Played

Thu, 07/15/2010 - 09:30
The FDA advisory panel's crucial vote leaves a lot of room for interpretation, as news headlines show.


A.M. Vitals: Glaxo Takes $2.4 Billion Charge Over Lawsuits

Thu, 07/15/2010 - 07:31
Also: meaningful use likely to benefit GE and others; early Alzheimer's diagnosis less costly; lobbying over preventive services; weight loss drugs.


This Blog Post is About Death. Please Read it Anyway.

Wed, 07/14/2010 - 16:01
The U.S. was 9th on the quality of death index, primarily because of the high cost of end-of-life care.


How the FDA Panel’s Votes on Avandia Went Down

Wed, 07/14/2010 - 15:16
On the final vote, most panelists recommended Avandia stay on the market but have more label warnings or a restricted use.


What’s the Meaning of Tau in Alzheimer’s Disease?

Wed, 07/14/2010 - 10:19
Alzheimer's drugs may also reduce the presence of a protein called tau -- but what does that mean?


What Everyone’s Saying About the Meaningful Use Requirements

Wed, 07/14/2010 - 09:55
Comments from doctors, health IT companies and industry groups on electronic medical record requirements.


A.M. Vitals: Avandia Meeting, Day One: ‘Garbage’ Data and Court Settlements

Wed, 07/14/2010 - 08:08
Also: a new head for PhRMA; Maine wants out, temporarily, of one health-overhaul requirement; a union's suit against Pfizer.


Making it Easier to Diagnose Alzheimer’s Disease

Tue, 07/13/2010 - 17:11
The new criteria are a “reflection of the conviction of the field that early identification is successful for the treatment of disease," one expert says.


Bill Gates Talks AIDS Vaccine Potential, Research Funding

Tue, 07/13/2010 - 16:42
Gates in March 2005 said that if a vaccine for the disease was found within ten years he would “eat my hat.”


Survey: 36% of Docs Don’t Believe in Reporting Impaired Colleagues

Tue, 07/13/2010 - 15:19
Most of the respondents -- 69% -- said they felt prepared to deal with colleagues who were significantly impaired, and 64% said the same about incompetent co-workers.